Jeffery P. Struewing

27.3k citations

81 papers · 7.7k indexed · 3 hit papers · h-index 37

Genetics top 0.2%
Molecular Biology top 2%
Oncology top 1%
Cancer Research top 0.5%
Pathology and Forensic Medicine top 0.5%

Co-authors: Lawrence C. Brody Margaret A. Tucker Sholom Wacholder Patricia Hartge Mary McAdams Nicholas C. Dracopoli Christopher J. Hussussian M. A. Tucker
Topics: BRCA gene mutations in cancer (43 papers)Cancer Genomics and Diagnostics (22 papers)DNA Repair Mechanisms (16 papers)
Cited by: Genetics Reproductive Medicine Cancer Research
Journals: New England Journal of Medicine The Lancet Nature Genetics
Partner nations: United States Israel Canada

In The Last Decade

Jeffery P. Struewing

81 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews

1997 1.7k citations Jeffery P. Struewing, Patricia Hartge et al. New England Journal of Medicine profile →
Germline p16 mutations in familial melanoma

1994 939 citations Jeffery P. Struewing et al. Nature Genetics profile →
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1995 512 citations Jeffery P. Struewing, Dvorah Abeliovich et al. Nature Genetics profile →

Peers

Countries citing papers authored by Jeffery P. Struewing

Since Specialization

Citations

This map shows the geographic impact of Jeffery P. Struewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffery P. Struewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffery P. Struewing more than expected).

Fields of papers citing papers by Jeffery P. Struewing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffery P. Struewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffery P. Struewing. The network helps show where Jeffery P. Struewing may publish in the future.

Co-authorship network of co-authors of Jeffery P. Struewing

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffery P. Struewing. A scholar is included among the top collaborators of Jeffery P. Struewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffery P. Struewing. Jeffery P. Struewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meeting Research Needs with Postmortem Biospecimen Donation: Summary of Recommendations for Postmortem Recovery of Normal Human Biospecimens for Research 2013 ·Biopreservation and Biobanking ·Neil R. Mucci,Helen M. Moore,Lori E. Brigham,Charles A. Goldthwaite,A. Roger Little,Nicole C. Lockhart,(unknown),Jeffery P. Struewing,(unknown),Carolyn C. Compton	8
2	No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families 2010 ·Breast Cancer Research and Treatment ·Larissa A. Korde,Christine M. Mueller,Jennifer T. Loud,Jeffery P. Struewing,(unknown),Mark H. Greene,L. Phuong	18
3	The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies 2007 ·BMC Genetics ·Lutécia H. Mateus Pereira,Marbin Pineda,(unknown),(unknown),Mark H. Greene,Kenneth Offit,Nathan A. Ellis,Jinghui Zhang,Andrew Collins,Jeffery P. Struewing	6
4	Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses 2006 ·Human Genetics ·Montserrat García‐Closas,Kathleen M. Egan,Polly A. Newcomb,Louise A. Brinton,Linda Titus‐Ernstoff,Stephen J. Chanock,Robert Welch,Jolanta Lissowska,Beata Pepłońska,Neonila Szeszenia‐Dąbrowska,Witold Zatoński,Alicja Bardin‐Mikolajczak,Jeffery P. Struewing	129
5	DNA damage in breast cancer plus another primary cancer, early onset breast cancer, thyroid cancer and cancer-free individuals 2004 ·Cancer Research ·Alice J. Sigurdson,Deirdre A. Hill,Michael Hauptmann,Bruce H. Alexander,Michele M. Doody,C. Thomas,Jeffery P. Struewing,Irene M. Jones	1
6	XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk 2004 ·British Journal of Cancer ·Andrea Baccarelli,Donato Calista,Paola Minghetti,Barbara Marinelli,Benedetta Albetti,(unknown),Mohammad Hedayati,L. Grossman,G Landi,Jeffery P. Struewing,M. T. Landi	52
7	BRCA1 and sex ratio 2004 ·European Journal of Human Genetics ·Jeffery P. Struewing,Patricia Hartge,Sholom Wacholder,Margaret A. Tucker,Mark H. Greene	3
8	A Natural History of Melanomas and Dysplastic Nevi: An Atlas of Lesions in Melanoma-Prone Families 2003 ·Journal of the Dermatology Nurses’ Association ·Mary C. Fraser,Alisa M. Goldstein,Jeffery P. Struewing,(unknown),Wallace H. Clark,(unknown),Laura Fontaine,Margaret A. Tucker,(unknown),(unknown)	6
9	Breast Cancer Risk in Ashkenazi BRCA1/2 Mutation Carriers: Effects of Reproductive History 2002 ·Epidemiology ·Patricia Hartge,Nilanjan Chatterjee,Sholom Wacholder,Lawrence C. Brody,Margaret A. Tucker,Jeffery P. Struewing	23
10	Patients with Double Primary Tumors in the Breast and Ovary— Clinical Characteristics and BRCA1–2 Mutations Status 2000 ·Gynecologic Oncology ·Ami Fishman,(unknown),Angela Chetrit,Liat Lerner‐Geva,(unknown),Dan Beck,(unknown),Gilad Ben‐Baruch,Benjamin Piura,(unknown),Jeffery P. Struewing,Baruch Modan	17
11	Histopathologic Features of Ovaries at Increased Risk for Carcinoma 1999 ·International Journal of Gynecological Pathology ·Mark E. Sherman,Jennifer Lee,R. Tucker Burks,Jeffery P. Struewing,Robert J. Kurman,Patricia Hartge	39
12	The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews 1998 ·Nature Genetics ·Trevor Woodage,(unknown),Sholom Wacholder,Patricia Hartge,Jeffery P. Struewing,Mary McAdams,Steven J. Laken,Margaret A. Tucker,Lawrence C. Brody	129
13	Automated Detection of Prevalent Mutations in BRCA1 and BRCA2 Genes, Using a Fluorogenic PCR Allelic Discrimination Assay 1997 ·Genetic Testing ·Mohammad Reza Abbaszadegan,Jeffery P. Struewing,K M Brown,(unknown),Federico Goodsaid,Robert E. Gore‐Langton,Mark Hughes	13
14	The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jewsbreakdown → 1997 ·New England Journal of Medicine ·Jeffery P. Struewing,Patricia Hartge,Sholom Wacholder,(unknown),(unknown),Mary McAdams,(unknown),Lawrence C. Brody,Margaret A. Tucker	1677
15	The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% 1996 ·Nature Genetics ·(unknown),Jeffery P. Struewing,(unknown),Susan L. Neuhausen,Lawrence C. Brody,Michael M. Kaback,Bruce R. Haas,Larry Norton,Patrick I. Borgen,Suresh C. Jhanwar,David E. Goldgar,Harry Ostrer,Kenneth Offit	298
16	The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsbreakdown → 1995 ·Nature Genetics ·Jeffery P. Struewing,Dvorah Abeliovich,Tamar Peretz,(unknown),Michael M. Kaback,Francis S. Collins,Lawrence C. Brody	512
17	The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. 1993 ·American Journal of Public Health ·Jeffery P. Struewing,Kenneth C. Hyams,John E. Tueller,Gregory C. Gray	85
18	Oral Erythromycin Prophylaxis against Streptococcus pyogenes Infection in Penicillin-Allergic Military Recruits: A Randomized Clinical Trial 1992 ·The Journal of Infectious Diseases ·(unknown),Jeffery P. Struewing,Kenneth C. Hyams,Edward L. Kaplan,(unknown),Gregory C. Gray	10
19	Efficacy of Hepatitis B Vaccination in Primary School Children from a Village Endemic for Schistosoma mansoni 1992 ·The Journal of Infectious Diseases ·S. Bassily,G. Thomas Strickland,M.F. Abdel-Wahab,(unknown),Shaker Narooz,(unknown),Niel T. Constantine,Jeffery P. Struewing	15
20	AN EPIDEMIC OF RESPIRATORY COMPLAINTS EXACERBATED BY MASS PSYCHOGENIC ILLNESS IN A MILITARY RECRUIT POPULATION 1990 ·American Journal of Epidemiology ·Jeffery P. Struewing,Gregory C. Gray	22

About Jeffery P. Struewing

Jeffery P. Struewing is a scholar working on Genetics, Cancer Research and Reproductive Medicine, having authored 81 papers that have together received 7.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (43 papers), Cancer Genomics and Diagnostics (22 papers) and DNA Repair Mechanisms (16 papers). The work is most often cited by research in Genetics (4.4k citations), Reproductive Medicine (1.1k citations) and Cancer Research (1.9k citations). Jeffery P. Struewing has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Lawrence C. Brody, Margaret A. Tucker, Sholom Wacholder, Patricia Hartge, Mary McAdams, Nicholas C. Dracopoli, Christopher J. Hussussian, M. A. Tucker, Delphine S. Ally and Paul Higgins. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact